Amylyx Pharmaceuticals, Inc.
← Back to AMLX Overview

Amylyx Pharmaceuticals, Inc. (AMLX)

Earnings & Profitability History

Latest EPS

$-0.28

Net Income

-32999000

Financial Fundamentals

AMLXQuarterly Data • 5Y View

Historical Data Table

Quarterly Net Income & EPS

DateNet Income ($B)NI YoY %TTM NIEPSEPS YoY %TTM EPS
2025-12-31-0.03+12.1%-0.14-0.28+49.1%-1.53
2025-09-30-0.03+52.7%-0.15-0.37+65.4%-1.80
2025-06-30-0.04+43.0%-0.19-0.46+57.0%-2.50
2025-03-31-0.04+69.8%-0.22-0.42+76.0%-3.11
2024-12-31-0.04-893.6%-0.30-0.55-883.5%-4.44
2024-09-30-0.07-448.0%-0.26-1.07-445.2%-3.82
2024-06-30-0.07-429.3%-0.17-1.07-424.2%-2.44
2024-03-31-0.12-7652.0%-0.07-1.75-7515.3%-1.04
2023-12-310.00+111.1%0.050.07+110.8%0.73
2023-09-300.02+138.9%0.000.31+133.7%0.01
2023-06-300.02+140.8%-0.070.33+135.5%-1.22
2023-03-310.00+103.3%-0.150.02+102.5%-2.48
2022-12-31-0.04-50.7%-0.20-0.65-27.5%-3.43
2022-09-30-0.05-132.3%-0.18-0.92-119.0%-3.29
2022-06-30-0.05-146.6%-0.15-0.93-93.8%-2.79
2022-03-31-0.05-229.5%-0.12-0.93-190.6%-2.34
2021-12-31-0.03-229.9%-0.09-0.51-168.4%-1.73
2021-09-30-0.02-0.07-0.42-1.41
2021-06-30-0.02-0.48
2021-03-31-0.01-0.32
2020-12-31-0.01-0.19

Annual Performance

YearNet Income ($B)Growth %EPSEPS Growth %
2025-0.14+52.0%-1.53+65.5%
2024-0.30-712.4%-4.43-706.8%
20230.05+124.8%0.73+124.5%
2022-0.20-125.6%-2.98-96.1%
2021-0.09-108.0%-1.52-92.4%
2020-0.04-185.4%-0.79-203.8%
2019-0.01-0.26